首页> 外文期刊>Die Pharmazie >Preparation of rosiglitazone maleate sustained-release floating microspheres for improved bioavailability.
【24h】

Preparation of rosiglitazone maleate sustained-release floating microspheres for improved bioavailability.

机译:制备马来酸罗格列酮缓释漂浮微球以提高生物利用度。

获取原文
获取原文并翻译 | 示例
           

摘要

The object of this study was to prepare rosiglitazone maleate (RM) sustained-release floating microspheres and investigate their pharmacokinetics. RM microspheres were prepared with ethyl cellulose (EC) and octadecyl alcohol as the carrier materials by an emulsion-solvent diffusion method, and the properties of morphology in vitro floating capability, drug loading (DL), entrapment efficiency (EE), in vitro release and in vivo pharmacokinetics were investigated. The prepared microspheres had a completely spherical shape. The percentage of microspheres floating after 12 h was (91.45 +/- 1.62)%, and the DL and EE were (9.31 +/- 0.31)% and (89.55 +/- 1.65)% respectively. Pharmacokinetic studies demonstrated that the RM floating microspheres were superior to commercial tablets in terms of the decrease in peak plasma concentration and maintenance of RM concentration in plasma. The area under the curve of plasma concentration-time (AUC) of the floating microspheres was equivalent to that of reference tablets. The results showed that floating microspheres are a feasible approach for the sustained-release preparation of drugs which have limited absorption sites in the upper small intestine.
机译:这项研究的目的是制备马来酸罗格列酮(RM)缓释漂浮微球并研究其药代动力学。以乳化-溶剂扩散法制备了以乙基纤维素(EC)和十八烷基醇为载体的RM微球,并考察了其体外漂浮能力,载药量(DL),包封率(EE),体外释放的形态学性质。并研究了体内药代动力学。制备的微球具有完全球形的形状。 12小时后漂浮的微球的百分比为(91.45 +/- 1.62)%,DL和EE分别为(9.31 +/- 0.31)%和(89.55 +/- 1.65)%。药代动力学研究表明,就峰值血浆浓度的降低和血浆中RM浓度的维持而言,RM漂浮微球优于商业片剂。漂浮的微球的血浆浓度-时间(AUC)曲线下的面积等于参考片剂的面积。结果表明,漂浮微球是缓释制剂的一种可行方法,该药物在小肠上部的吸收位点有限。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号